Voyager Therapeutics, a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS), today announced that Bernard Ravina, M.D., M.S.C.E., has joined the company as Vice President of Clinical Development and Dinah Sah, Ph.D., has been named a permanent member of the leadership team after serving as Interim Senior Vice President of Neuroscience since the company’s launch early this year.
Help employers find you! Check out all the jobs and post your resume.
